Apeloa Pharmaceutical Co.,Ltd
000739
Ранг среди акций
#4293
Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical... Apeloa Pharmaceutical Co.,Ltd operates as a comprehensive pharmaceutical enterprise, specializing in the discovery, development, production, and global distribution of a diverse range of medicinal products. Its market reach spans China and various international territories. The company strategically focuses its product portfolio on several critical medical fields, including cardiovascular and cerebrovascular health, anti-infective treatments, antiviral therapies, and oncology (cancer treatment), alongside other therapeutic categories. Apeloa's offerings encompass finished pharmaceutical preparations, raw material intermediates (active pharmaceutical ingredients and their precursors), and veterinary medicines. These products are primarily recognized and sold under key brands such as Tianliwei, Beshin, Yosemade, and Jutai, among others. Furthermore, the company extends its expertise to other pharmaceutical businesses by providing contract research, development, and manufacturing (CDMO) services. The corporate headquarters for Apeloa Pharmaceutical Co.,Ltd are located in Dongyang, China.
Цена акции
$3.13
Рыночная капитализация
$3.62B
Изменение (1 день)
-1.42%
Изменение (1 год)
46.59%
Страна
CN
Торговля Apeloa Pharmaceutical Co.,Ltd (000739)
Категория
Healthcare
Количество находящихся в обращении акций Apeloa Pharmaceutical Co.,Ltd (000739)
Количество акций в обращении на June 2026: 1.13B
Согласно последним финансовым отчетам и цене акций Apeloa Pharmaceutical Co.,Ltd, текущее количество акций в обращении составляет 1.13B. На конец December 2024 у компании было 1.16B акций в обращении. Количество акций в обращении обычно зависит от сплитов и обратного выкупа акций.
История количества акций в обращении Apeloa Pharmaceutical Co.,Ltd (000739) с 2000 по 2026
Акции в обращении на конец каждого года
| Год | Акции в обращении | Изменить |
|---|---|---|
| 2026 (TTM) | 1.13B | -2.09% |
| 2025 | 1.15B | -0.45% |
| 2024 | 1.16B | -0.93% |
| 2023 | 1.17B | 0.00% |
| 2022 | 1.17B | -0.78% |
| 2021 | 1.18B | 0.00% |
| 2020 | 1.18B | 0.00% |
| 2019 | 1.18B | 0.00% |
| 2018 | 1.18B | 2.52% |
| 2017 | 1.15B | 0.58% |
| 2016 | 1.14B | -0.33% |
| 2015 | 1.15B | 6.80% |
| 2014 | 1.07B | 34.75% |
| 2013 | 796.95M | 63.70% |
| 2012 | 486.82M | -49.99% |
| 2011 | 973.47M | 41.65% |
| 2010 | 687.25M | 2.98% |
| 2009 | 667.33M | -0.02% |
| 2008 | 667.43M | 5.15% |
| 2007 | 634.73M | 11.69% |
| 2006 | 568.31M | -10.46% |
| 2005 | 634.73M | 0.00% |
| 2004 | 634.73M | 0.00% |
| 2003 | 634.73M | 0.00% |
| 2002 | 634.73M | 0.00% |
| 2001 | 634.73M | 0.00% |
| 2000 | 634.73M | 0.00% |
Акции в обращении у аналогичных компаний или конкурентов
| Компания | Акции в обращении | Разница | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | 112.49% |
IN
|
